The Phonak Sphere Infinio Ultra is a premium behind-the-ear prescription hearing aid released in 2026, earning a SoundScore of 4.58/5 in HearAdvisor's lab testing. At $4,898, this device represents Phonak's flagship offering and delivers strong overall performance across our standardized test protocol.
The standout strength of this device is its speech performance. Speech in noise scores an excellent 4.4/5, measuring +2.87 points above the prescription hearing aid category average of 1.53/5—a substantial margin that reflects meaningful real-world benefit in challenging listening environments. Speech in quiet is equally impressive at 4.7/5, sitting +1.27 points above the category average. These results suggest the Sphere Infinio Ultra excels where it matters most for daily communication.
Music streaming delivers a solid 3.3/5, measuring +0.69 points above the category average. Own-voice comfort scores 2.8/5, which is above the category average by +0.07 points but remains mixed in absolute terms—users sensitive to their own voice may notice some occlusion effects. Feedback handling measures 4.2/5, which is strong in absolute terms, though it falls -0.54 points below the category average of 4.74/5.
The Sphere Infinio Ultra is best suited for users who prioritize speech clarity, particularly in noisy environments, and are willing to invest in premium technology. Those considering alternatives may note that the standard Phonak Sphere Infinio scores similarly at 4.64/5 at a lower price point.
